Home
Lynwood Capital Management reported a 6.1% stake in Rein Therapeutics RNTX · 4,750,000 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 6.1%
- Last report
- First report
- Shares held
- 4,750,000 sh
- Class
- Common Stock, $0.001 par value per share
- Event date
- 26/05/04
- Filed
- 26/05/08
First 5%+ report · 6.1% stake
Rein Therapeutics trades, last 26 weeks
What else happened in Rein Therapeutics around then
Filed or reported within 30 days of the trade day · 04/04~06/03Lynwood Capital Management's other 5% stake reports
- Lynwood Capital Management
5% stakeKazia Therapeutics
5% stakeKazia Therapeutics
KZIA
4.6% stake
264,980,500 sh
4.6% stake
Filed 08/14
- Lynwood Capital Management
5% stakeRein Therapeutics
5% stakeRein Therapeutics
RNTX
5% stake
4,280,500 sh
5% stake
Filed 08/14
- Lynwood Capital Management
5% stakeKazia Therapeutics
5% stakeKazia Therapeutics
KZIA
5.4% stake
307,998,500 sh
5.4% stake
Filed 01/23
